Cargando…
Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
INTRODUCTION: Neuroblastoma is a malignant pediatric cancer derived from neural crest cells. It is characterized by a generalized reduction of mitochondrial oxidative phosphorylation. The goal of the present study was to investigate the effects of calorie restriction and ketogenic diet on neuroblast...
Autores principales: | Morscher, Raphael Johannes, Aminzadeh-Gohari, Sepideh, Feichtinger, René Gunther, Mayr, Johannes Adalbert, Lang, Roland, Neureiter, Daniel, Sperl, Wolfgang, Kofler, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459995/ https://www.ncbi.nlm.nih.gov/pubmed/26053068 http://dx.doi.org/10.1371/journal.pone.0129802 |
Ejemplares similares
-
Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
por: Morscher, Raphael Johannes, et al.
Publicado: (2016) -
A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2017) -
The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome
por: Vidali, Silvia, et al.
Publicado: (2017) -
Ketogenic diet in the treatment of cancer – Where do we stand?
por: Weber, Daniela D., et al.
Publicado: (2019) -
Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma
por: Feichtinger, René Günther, et al.
Publicado: (2019)